Vitamin Shoppe, Inc (VSI) Director John D. Bowlin Purchases 40,000 Shares
Vitamin Shoppe, Inc (NYSE:VSI) Director John D. Bowlin bought 40,000 shares of the stock in a transaction that occurred on Friday, August 25th. The shares were purchased at an average price of $5.50 per share, for a total transaction of $220,000.00. Following the completion of the acquisition, the director now owns 56,028 shares of the company’s stock, valued at approximately $308,154. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of Vitamin Shoppe, Inc (VSI) traded down 4.76% during midday trading on Tuesday, hitting $5.00. 1,122,350 shares of the stock were exchanged. Vitamin Shoppe, Inc has a 1-year low of $4.95 and a 1-year high of $28.41. The stock’s 50-day moving average price is $8.98 and its 200-day moving average price is $14.78. The firm’s market capitalization is $116.12 million.
Vitamin Shoppe (NYSE:VSI) last posted its earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share for the quarter, missing analysts’ consensus estimates of $0.39 by $0.16. Vitamin Shoppe had a negative net margin of 11.98% and a positive return on equity of 8.33%. The firm had revenue of $304.84 million during the quarter, compared to the consensus estimate of $314.74 million. During the same period in the prior year, the company posted $0.55 EPS. The firm’s revenue was down 8.4% compared to the same quarter last year. On average, analysts forecast that Vitamin Shoppe, Inc will post $0.79 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: This news story was posted by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/08/29/vitamin-shoppe-inc-vsi-director-john-d-bowlin-purchases-40000-shares.html.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. BNP Paribas Arbitrage SA increased its position in Vitamin Shoppe by 2.1% in the second quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock worth $108,000 after buying an additional 192 shares in the last quarter. Municipal Employees Retirement System of Michigan increased its position in Vitamin Shoppe by 18.1% in the second quarter. Municipal Employees Retirement System of Michigan now owns 9,410 shares of the specialty retailer’s stock worth $110,000 after buying an additional 1,440 shares in the last quarter. Mason Street Advisors LLC increased its position in Vitamin Shoppe by 7.0% in the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock worth $112,000 after buying an additional 366 shares in the last quarter. Wolverine Trading LLC purchased a new position in Vitamin Shoppe during the second quarter worth $131,000. Finally, UBS Asset Management Americas Inc. increased its position in Vitamin Shoppe by 17,041.4% in the second quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock worth $140,000 after buying an additional 11,929 shares in the last quarter. 96.86% of the stock is currently owned by institutional investors.
A number of equities analysts recently weighed in on the stock. Morgan Stanley set a $8.00 target price on shares of Vitamin Shoppe and gave the stock a “hold” rating in a report on Thursday, August 10th. Gabelli downgraded shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Thursday, May 11th. Goldman Sachs Group, Inc. (The) restated a “sell” rating and set a $6.00 target price (down from $13.00) on shares of Vitamin Shoppe in a report on Thursday, August 10th. TheStreet downgraded shares of Vitamin Shoppe from a “c-” rating to a “d” rating in a report on Wednesday, August 9th. Finally, ValuEngine downgraded shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Four investment analysts have rated the stock with a sell rating and seven have given a hold rating to the company. The company has a consensus rating of “Hold” and an average target price of $14.38.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.